IGF-1 LR3 is a variant of IGF-1, a product of Growth Hormone that stimulates cell growth[i] throughout the body, enabling growth and development, tissue strengthening, increased bone density, and healing.
With a total of 83 amino acids, IGF-1 LR3 research peptide has an extremely low affinity for insulin-like growth factor-binding proteins and has shown rapid improvement in metabolic stability. It is thus considered to be three times more potent than IGF-1. The peptide also offers a much longer half-life of 20-30 hours[ii], whereas IGF-1 only has a half-life of 12-15 hours.
The IGF-1 LR3 amino acid sequence is: MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA
According to research, the main purpose of IGF-1 LR3 is to increase the biological activity of IGF. When the IGF-1 LR3 chemical is active in the body, it functions differently depending on the types of tissues. For example, IGF-1 LR3 used in muscle tissue would make the muscle more sensitive to the effects of insulin. On the other hand, while it has been proven to aid fat reduction, it could also cause fat increase due to muscle mass increase, as research on animals has shown.
IGF1 is mainly associated with the human growth hormone, which maintains tissue health within the body. Produced in the liver, this long peptide is made possible by the pituitary gland – a tiny stricture at the base of the brain. Its role is primarily in the endocrine system to ensure hormone production and secretion run smoothly. It also regulates water levels in the body, signals milk production in pregnant mice, and boosts the body’s metabolism. Besides that, IGF1 LR3 plays a role in sex hormone production and is an integral part of mice growth.
According to research, IGF1 LR3 peptide therapy offers a number of health benefits. Although the effects may take anywhere between three and six months, numerous studies prove that igf-1 lr3 injections work efficiently with consistent use.
Here are the benefits of IGF-1/LR3 peptide, as research on animals has shown:
Doctors prescribe igf peptide to help multiple health issues. As per scientific research, it may also help with growth deficiencies and suffering from muscle atrophy. In the future, researchers believe that IGF 1 lr3 muscle gains peptide will be widely available in HIV/AIDS as the disease causes severe muscle loss.
Scientists have also witnessed the following IGF-1 lr3 results with regular consumption, as per clinical studies.
Structurally similar to insulin, research shows that short-term use of IGF-1 LR3 can both stabilize and lower blood sugar levels.
According to their study, eight healthy volunteers were tested on their responses to both IGF 1 and insulin, and the hypoglycemic responses to both hormones were almost identical in the doses used.
The most significant drop in blood glucose levels came after 30 minutes: 1.98±0.44 mmol per liter after IGF I and 1.78±0.29 after insulin.
This may even offer insight to scientists into preventing type 2 diabetes.
Recent studies show that IGF-1 LR3 is produced in response to Growth Hormone, which then induces cellular activities. Muscle growth is one response to the chemical.
According to recent scientific research, IGF-1 LR3 creates new muscle tissue by promoting protein synthesis and nitrogen retention. This results in the expansion of muscles through both hyperplasia (an increased number of muscle cells) and mitogenesis (the growth of new muscle fibers). Therefore, IGF-1 LR3 for muscle growth can certainly make muscle fibers bigger and increase the number of them, too, research has shown. Research has shown the peptide IGF-1 LR3 can even change the genetic capabilities in regard to muscle tissue and cell count.
IGF-1 LR3 is generally considered a safe product. It is intended to be a research product only and should not be used due to US law. This product should only be used for in vitro testing and laboratory experimentation by licensed, qualified professionals only. It is not a drug, food, or cosmetic.
With the rise in medical innovation, more doctors and scientists are studying the IGF-1 LR3 peptide benefits. So far, as of November 2023, the effects of this peptide on the body have shown some impressive effects, and the discoveries will continue as the research progresses.
IGF-1 LR3, a synthetic peptide variant of Insulin-like Growth Factor 1 (IGF-1), has been making waves in the world of non-human research. What sets it apart from native IGF-1 is the LR3 modification, which prolongs its half-life and ensures more prolonged activity in experimental models. Moreover, IGF-1 LR3 has a lower affinity for IGF-binding proteins, resulting in higher bioavailability and effectiveness in a range of research settings.
Non-human research has revealed the remarkable potential of IGF-1 LR3 in addressing conditions like muscle atrophy, injury recovery, and tissue regeneration. Through animal model studies, it has been observed that IGF-1 LR3 not only enhances muscle growth but also stimulates cell proliferation and differentiation while bolstering tissue repair mechanisms. These findings suggest that IGF-1 LR3 could significantly expand our knowledge of tissue regeneration and recovery processes in non-human subjects.
IGF-1 LR3 has emerged as an indispensable asset in cellular and molecular biology research, particularly in the areas of cell signaling, growth, and differentiation. This peptide has been crucial in unraveling the intricacies of the IGF-1 signaling pathway, which plays a pivotal role in cellular growth, metabolism, and survival. By fine-tuning IGF-1 signaling with IGF-1 LR3, researchers can gain invaluable insights into the underlying mechanisms that orchestrate these essential cellular processes.
IGF-1 LR3’s unique properties make it an appealing candidate for drug development. Its capacity to foster tissue regeneration, promote cell growth, and regulate metabolic processes has generated interest in its potential therapeutic applications. While current research is limited to non-human models, IGF-1 LR3 has exhibited promise in addressing various medical conditions, such as wound healing, tissue repair, and metabolic disorders.
The process of synthesizing IGF-1 LR3 involves solid-phase peptide synthesis, followed by the addition of a 13-amino acid extension at the N-terminus and a single amino acid substitution (Arg3) in the native IGF-1 sequence. These modifications provide increased stability, bioavailability, and biological activity compared to native IGF-1. As IGF-1 LR3 research advances, further modifications may be developed to enhance its effectiveness and broaden its potential applications.
IGF-1 LR3 research is still in its early stages, with many questions remaining to be answered. Future studies may focus on elucidating the precise mechanisms underlying its therapeutic effects, optimizing its synthesis and delivery, and investigating potential safety concerns related to its use. As our understanding of IGF-1 LR3 grows, it may become a powerful tool in the development of novel therapies for a wide range of non-human conditions.
Proper storage of IGF-1 LR3 is essential to maintain its stability and biological activity. The lyophilized peptide should be stored at -20°C in a sealed container to prevent degradation and contamination. Once reconstituted with sterile water, IGF-1 LR3 should be kept at 4°C and used within one week to ensure optimal activity. To minimize freeze-thaw cycles, it is recommended to aliquot the reconstituted peptide and store the aliquots at -20°C.
USD
EUR
GBP
CAD